Gyre Therapeutics, Inc. (GYRE) Q4 Earnings Miss Estimates

分组1 - Gyre Therapeutics, Inc. reported quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.08 per share, representing an earnings surprise of -50.00% [1] - The company posted revenues of $37.2 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.17%, compared to year-ago revenues of $27.87 million [2] - Gyre Therapeutics has surpassed consensus revenue estimates two times over the last four quarters [2] 分组2 - The stock has added about 18% since the beginning of the year, while the S&P 500 has declined by 1% [3] - The current consensus EPS estimate for the coming quarter is $0.09 on $44.5 million in revenues, and $0.27 on $162 million in revenues for the current fiscal year [7] - The Zacks Industry Rank for Medical - Biomedical and Genetics is currently in the top 36% of over 250 Zacks industries, indicating a favorable outlook for the industry [8]